|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | |
| A61K 9/14 | |||
| A61K 9/51 |
| (11) | Number of the document | 2416650 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10762524.6 |
| Date of filing the European patent application | 2010-04-09 | |
| (97) | Date of publication of the European application | 2012-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/030596 |
| Date | 2010-04-09 |
| (87) | Number | WO 2010/118365 |
| Date | 2010-10-14 |
| (30) | Number | Date | Country code |
| 168540 P | 2009-04-10 | US |
| (72) |
DESAI, Neil P., US
TAO, Chunlin, US
DE, Tapas, US
CI, Sherry Xiaopei, US
TRIEU, Vuong, US
|
| (73) |
Abraxis BioScience, LLC,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | NANOPARTICLE FORMULATIONS AND USES THEROF |
| NANOPARTICLE FORMULATIONS AND USES THEROF |